Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004–2013

Drug and Alcohol Dependence

Volumn 176, Issue , 2017, Pages 89-95

  Jones, Christopher M ^a   Christensen, Aleta ^b   Gladden, R Matthew ^b  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

Author keywords

Abuse; Injection; Overdose; Prescription opioid

Indexed keywords

CANNABIS; COCAINE; DIAMORPHINE; METHAMPHETAMINE; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CAUCASIAN; CHILD; DRUG DEPENDENCE TREATMENT; FEMALE; FULL TIME EMPLOYMENT; GEOGRAPHIC DISTRIBUTION; HOMELESSNESS; HUMAN; MALE; NARCOTIC DEPENDENCE; PRIORITY JOURNAL; SEX RATIO; TREND STUDY; UNITED STATES; YOUNG ADULT; DRUG DEPENDENCE; HOSPITALIZATION; INHALATIONAL DRUG ADMINISTRATION; INJECTION; MIDDLE AGED; OPIATE ADDICTION; SMOKING; STATISTICAL MODEL; TRENDS;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ANALGESICS, OPIOID; FEMALE; HOSPITALIZATION; HUMANS; INJECTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; SMOKING; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 85019936425     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2017.03.011     Document Type: Article

References (39)

1. Black, R.A., Trudeau, K.J., Cassidy, T.A., Budman, S.H., Butler, S.F., Associations between public health indicators and injecting prescription opioids by prescription opioid abusers in substance abuse treatment. J. Opioid Manag. 9 (2013), 5–17.
2. Compton, W.M., Volkow, N.D., Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 83 (2006), S4–S7.
3. Davis, W.R., Johnson, B.D., Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend. 92 (2008), 1–17.
4. Des Jarlais, D.C., Nugent, A., Solberg, A., Feelemyer, J., Mermin, J., Holtzman, D., Syringe service programs for persons who inject drugs in urban, suburban, and rural areas–United States, 2013. Morb. Mortal. Wkly. Rep. 64 (2013), 1337–1341.
5. Dowell, D., Haegerich, T.M., Chou, R., CDC guideline for prescription opioids for chronic pain -United States, 2016. MMWR. Recomm. Rep., 2016, 65 (NoRR-1), Retrieved on 17 November 2016 from: http://dx.doi/10.15585/mmwr.rr6501e1.
6. Havens, J.R., Walker, R., Leukefeld, C.G., Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. Drug Alcohol Depend. 87 (2007), 98–102.
7. Inciardi, J.A., Surratt, H.L., Cicero, T.J., Beard, R.A., Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med. 10 (2009), 537–548.
8. Jones, C.M., Campopiano, M., Baldwin, G., McCance-Katz, E., National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am. J. Public Health 105 (2015), e55–63.
9. Katz, N., Dart, R.C., Bailey, E., Trudeau, J., Osgood, E., Paillard, F., Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions. Am. J. Drug Alcohol Abuse 37 (2011), 205–217.
10. Katz, N., Abuse-deterrent opioid formulations: are they a pipe dream?. Curr. Rheumatol. Rep. 10 (2008), 11–18.
11. Kim, H.J., Fay, M.P., Feuer, E.J., Midthune, D.N., Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 19 (2000), 335–351.
12. Lake, S., Kennedy, M.C., Health outcomes associated with illicit prescription opioid injection: a systematic review. J. Addict. Dis. 35 (2016), 73–91.
13. Lankenau, S.E., Teti, M., Silva, K., Jackson Bloom, J., Harocopos, A., Treese, M., Initiation into prescription opioid misuse amongst young injection drug users. Int. J. Drug Policy 23 (2012), 37–44.
14. Lankenau, S.E., Kecojevic, A., Silva, K., Associations between prescription opioid injection and Hepatitis C virus among young injection drug users. Drugs 22 (2015), 35–42.
15. Mars, S.G., Bourgois, P., Karandinos, G., Montero, F., Ciccarone, D., Every ‘never' I ever said came true: transitions from opioid pills to heroin injecting. Int. J. Drug Policy 25 (2014), 257–266.
16. Mateu-Gelabert, P., Guarino, H., Jessell, L., Teper, A., Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City. J. Subst. Abuse Treat. 48 (2014), 13–20.
17. McCabe, S.E., Cranford, J.A., Boyd, C.J., Teter, C.J., Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict. Behav. 32 (2007), 1–16.
18. McCabe, S.E., Boyd, C.J., Cranford, J.A., Teter, C.J., Motives for non-medical use of prescription opioids among high school seniors in the United States: self-treatment and beyond. Arch. Pediatr. Adolesc. Med. 163 (2009), 739–744.
19. Paulozzi, L.J., Jones, C.M., Mack, K.A., Rudd, R.A., Vital signs: overdoses of prescription opioid pain relievers–United States, 1999–2008. Morb. Mortal. Wkly. Rep. 60 (2011), 1487–1492.
20. Paulozzi, L.J., Prescription drug overdoses: a review. J. Saf. Res. 43 (2012), 283–289.
21. Peavy, K.M., Banta-Green, C.J., Kingston, S., Hanrahan, M., Merrill, J.O., Coffin, P.O., Hooked on prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients. J. Psychoact. Drugs 44 (2012), 259–265.
22. Peters, P.J., Pontones, P., Hoover, K.W., Patel, M.R., Galang, R.R., Shields, J., Blosser, S.J., Spiller, M.W., Combs, B., Switzer, W.M., Conrad, C., Gentry, J., Khudyakov, Y., Waterhouse, D., Owen, S.M., Chapman, E., Roseberry, J.C., McCants, V., Weidle, P.J., Broz, D., Samandari, T., Mermin, J., Walthall, J., Brooks, J.T., Duwve, J.M., HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. N. Engl. J. Med. 375 (2016), 229–239.
23. Pollini, R.A., Banta-Green, C.J., Cuevas-Mota, J., Metzner, M., Teshale, E., Garfein, R.S., Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst. Abuse Rehabil. 2 (2011), 173–180.
24. Ronan, M.V., Herzig, S.J., Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002–2012. Health Aff. (Millwood) 35 (2016), 832–837.
25. Roux, R., Carrieri, M.P., Keijzer, L., Dasgupta, N., Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug users. Drug Alcohol Rev. 30 (2011), 287–290.
26. Roy, E., Arruda, N., Bourgois, P., The growing popularity of prescription opioid injection in downtown Montreal: new challenges for harm reduction. Subst. Use Misuse 46 (2011), 1142–1150.
27. Rudd, R.A., Aleshire, N., Zibbell, J.E., Gladden, R.M., Increase in drug and opioid overdose deaths–United States, 2000–2014. Morb. Mortal. Wkly. Rep. 64 (2016), 1378–1382.
28. Silva, K., Schrager, S.M., Kecojevic, A., Lankenau, S.E., Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs. Drug Alcohol Depend. 125 (2013), 104–110.
29. Spoth, R., Trudeau, L., Shin, C., Ralston, E., Redmond, C., Greenberg, M., Feinberg, M., Longitudinal effects of universal preventive intervention on prescription drug misuse: three randomized controlled trials with late adolescents and young adults. Am. J. Public Health 103 (2013), 665–672.
30. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, 2015. Treatment Episode Data Set (TEDS): 2003–2013. National Admissions to Substance Abuse Treatment Services. BHSIS Series S-75, HHS Publication No. (SMA.) 15–4934. Rockville, MD.
31. Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set Admissions Public Use Files. 2016 Retrieved on 15 March 2016 from: http://wwwdasis.samhsa.gov/dasis2/teds.htm.
32. Surratt, H., Kurtz, S.P., Cicero, T.J., Alternate routes of administration and risk for HIV among prescription opioid abusers. J. Addict. Dis. 30 (2011), 334–341.
33. Suryaprasad, A.G., White, J.Z., Xu, F., Eichler, B.A., Hamilton, J., Patel, A., Hamdounia, S.B., Church, D.R., Barton, K., Fisher, C., Macomber, K., Stanley, M., Guilfoyle, S.M., Sweet, K., Liu, S., Iqbal, K., Tohme, R., Sharapov, U., Kupronis, B.A., Ward, J.W., Holmberg, S.D., Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin. Infect. Dis. 59 (2014), 1411–1419.
34. U.S. Department of Health and Human Services, Addressing Prescription Drug Abuse in the United States: Current Activities and Future Opportunities., 2013 Retrieved on 7 November 2016 from: http://www.cdc.gov/drugoverdose/pdf/hhs_prescription_drug_abuse_report_09.2013.pdf.
35. Van Handel, M.M., Rose, C.E., Hallisey, E., Kolling, J.L., Zibbell, J.E., Lewis, B., Bohm, M.K., Jones, C.M., Flanagan, B.E., Siddiqi, A.E., Iqbal, K., Dent, A.L., Mermin, J.H., McCray, E., Ward, J.W., Brooks, J.T., County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J. Acquir. Immun. Defic. Syndr. 73 (2016), 323–331.
36. Vosler, P.S., Ferguson, B.J., Contreras, J.L., Wang, E.W., Schaitkin, B.M., Lee, S., Clinical and pathologic characteristics of intranasal abuse of combined opioid-acetaminophen medications. Int. Forum Allergy Rhinol. 4 (2014), 839–844.
37. Young, A.M., Havens, J.R., Leukefeld, C.G., Route of administration for illicit prescription opioids: a comparison of rural and urban drug users. Harm Reduct. J. 7 (2010), 1–7.
38. Zibbell, J.E., Hart-Malloy, R., Barry, J., Fan, L., Flanigan, C., Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. Am. J. Public Health 104 (2014), 2226–2232.
39. Zibbell, J.E., Iqbal, K., Patel, R.C., Suryaprasad, A., et al. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤ 30 years–Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012. Morb. Mortal. Wkly. Rep. 64 (2015), 53–58.